Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 11/02/23 | 8-K | Form 8-K: Current report filing |
|
4 |
| 10/31/23 | 424B3 | Form 424B3: Prospectus filed pursuant to Rule 424(b)(3) | 9 | |
| 10/30/23 | EFFECT | Form EFFECT: Notice of Effectiveness | 1 | |
| 10/27/23 | 8-K | Form 8-K: Current report filing |
|
3 |
| 10/26/23 | CORRESP | Form CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission. | 1 | |
| 10/25/23 | S-3/A | Form S-3/A: Registration statement for specified transactions by certain issuers | 6 | |
| 10/12/23 | UPLOAD | Form UPLOAD: SEC-generated letter | 1 | |
| 10/05/23 | S-3 | Form S-3: Registration statement for specified transactions by certain issuers | 15 | |
| 10/02/23 | DEF 14A | Form DEF 14A: Definitive proxy statements | 16 | |
| 09/22/23 | PRE 14A | Form PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition | 16 |
- Previous Page
- Page 1
- …
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
- Page 18
- Page 19
- Page 20
- …
- Page 120
- Next Page